Relevium Technologies Inc. — Investor Relations & Filings
Relevium Technologies Inc. is a healthcare company operating within the health and wellness markets, primarily focused on growth through the identification, acquisition, and operation of established brands and businesses. The company utilizes e-commerce channels for distribution. Its product portfolio encompasses two main areas: magnetic therapy devices for pain relief, including active back, ankle, and knee supports; and a range of dietary supplements, nutraceuticals, sports nutrition products, and cosmeceuticals, primarily marketed under the Bioganix brand. Relevium emphasizes proprietary product development and holds regulatory approvals, such as Natural Product Numbers (NPNs), for its nutraceutical offerings.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 52-109FV2 - Certification of interim filings - CFO (E).pdf | 2023-03-13 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-03-13 | English | |
| Interim financial statements/report – English.pdf | 2023-03-13 | English | |
| Interim MD&A - English.pdf | 2023-03-13 | English | |
| 52-109FV2 - Certification of interim filings - CEO (E).pdf | 2023-03-13 | English | |
| Interim financial statements/report – English.pdf | 2023-03-13 | English |
Browse filings by year
4 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
|
Adaptimmune Therapeutics PLC
Commercial-stage biopharma developing TCR T-cell therapies …
|
ADAP | GB | Manufacturing |
Relevium Technologies Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47081/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47081 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47081 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47081 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47081}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Relevium Technologies Inc. (id: 47081)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.